515 research outputs found

    A European Advanced Technology Programme for ADS Accelerator Development

    No full text
    Consecutive to the work of the European Technical Working Group on ADS, the Preliminary Design Study of an Experimental ADS was launched in 2001 as a 5th Framework Program EC project. A special working package was dedicated to the accelerator design, and in particular taking into account that the issue of “beam trips” could be a potential “show-stopper” for ADS technology in general. A reference solution, based on a linear superconducting accelerator with its associated doubly achromatic beam line has been worked out up to some detail. For very high reliability, the proposed design is intrinsically fault tolerant, relying especially on highly modular “de-rated” components associated to a fast digital feedback system. A programme for the remaining R&D, focused on experimental reliability demonstration of prototypical components, has been elaborated. This R&D will be performed in the 6th Framework Program EC project EUROTRANS, which presently is just starting

    Alternative treatments for oral bisphosphonate-related osteonecrosis of the jaws: a pilot study comparing fibrin rich in growth factors and teriparatide

    Get PDF
    Objectives: The aim of this study is to describe and compare the evolution of recurrent bisphosphonate-related osteonecrosis of the jaws (BRONJ) in patients treated with plasma rich in growth factors or teriparatide. Material and Methods: Two different types of treatments were applied in patients diagnosed of recurrent BRONJ in a referral hospital for 1.100.000 inhabitants. In the group A, plasma rich in growth factors was applied dur - ing the surgery. In the group B, the treatment consisted in the subcutaneous administration of teriparatide. All the cases of BRONJ should meet the following conditions: recurrent BRONJ, impossibility of surgery in stage 3 Ruggiero classification and absence of diagnosed neoplastic disease. Clinical and radiographic evolution of the patients from both groups was observed. Results: Nine patients were included, 5 in group A and 4 in group B. All the patients were women on oral bis- phosphonate therapy for primary osteoporosis (5 patients) or osteoporosis-related to the use of corticosteroids (4 patients). Alendronate was the most common oral bisphosphonate associated with BRONJ in our study (four patients in group A and two in group B). The mean age was 72,8 years in the group A and 73,5 years in the group B. All the patients from group A showed a complete resolution of their BRONJ. Only one patient in the group B showed the same evolution. Conclusions: In our series, the plasma rich in growth factors showed better results than the teriparatide in the treatment of recurrent BRONJ

    Ferromagneticlike Closure Domains in Ferroelectric Ultrathin Films: First-Principles Simulations

    Get PDF
    We simulate from first principles the energetic, structural, and electronic properties of ferroelectric domains in ultrathin SrRuO3/BaTiO3/SrRuO3 ferroelectric capacitors in short circuit. The domains are stabilized down to two unit cells at zero temperature, adopting the form of a domain of closure, common in ferromagnetic thin films. The domains are closed by the in-plane relaxation of the atoms in the first SrO layer of the electrode, which behaves more like SrO in highly polarizable SrTiO3 than in metallic SrRuO3. Even if small, these lateral displacements are very important to stabilize the domains and might provide some hints to explain why some systems break into domains while others remain in a monodomain configuration. An analysis of the electrostatic potential reveals preferential points of pinning for charged defects at the ferroelectric-electrode interface, possibly playing a major role in film fatigue

    Spanish shrimp (Pandalus borealis) fishery in Flemish cap in 1997

    Get PDF
    4 páginas, 4 tablas.-- Scientific Council MeetingIn 1997 one Spanish trawler have been involved in the shrimp fishery in Flemish Cap (NAFO Div. 3M) from March to May. A scientific observer remained on board this trawler during all the fishing period, providing information on the fishing activity and carrying out biological sampling. The gear used was a twin trawl, with a 19 mm bar spacing sorting grate. In this paper, the main results of this fishery are presented.Peer reviewe

    A reference accelerator scheme for ADS applications

    No full text
    Accelerator Driven Systems (ADS) for transmutation of nuclear waste typically require 350 MeV–1 GeV accelerators delivering proton fluxes of 5–10 mA for demonstrators, and 20–50 mA for large industrial systems. Thus, such machines belong to the category of the so-called HPPA (High-Power Proton Accelerators), with multi-megawatt beam power. HPPA are presently developed and constructed at great pace for their broad utility in fundamental or applied science. Compared to other HPPA, many features and requirements are similar for the ADS driver. However, there is a need for exceptional reliability: because of the induced thermal stress to the sub-critical core, the number of unwanted “beam-trips” should not exceed a few per year, a requirement that is several orders of magnitude above usual performance. Consecutive to the work of the European Technical Working Group (ETWG) on ADS, the Preliminary Design Study of an Experimental ADS (PDS-XADS) was launched in 2001 as a 5th Framework Program EC project.1 A special Working Package (WP3) was dedicated to the accelerator design, taking especially into account that the issue of “beam-trips” could be a potential “show-stopper” for ADS technology in general. A reference solution, based on a linear superconducting accelerator with its associated doubly achromatic beam line, has been worked out to some detail. For high reliability, the proposed design is intrinsically fault tolerant, relying on highly modular “de-rated” components associated to a fast digital feedback system. The proposed solution also appears to be robust concerning operational aspects like maintenance and radioprotection. A roadmap for construction as well as the required consolidated budget was elaborated. A program for the remaining R&D, focused on experimental reliability demonstration of prototypical components has been elaborated. This R&D will be performed in the 6th Framework Program EC project EUROTRANS,2 which presently is just starting

    Systematic generation of finite-range atomic basis sets for linear-scaling calculations

    Full text link
    Basis sets of atomic orbitals are very efficient for density functional calculations but lack a systematic variational convergence. We present a variational method to optimize numerical atomic orbitals using a single parameter to control their range. The efficiency of the basis generation scheme is tested and compared with other schemes for multiple zeta basis sets. The scheme shows to be comparable in quality to other widely used schemes albeit offering better performance for linear-scaling computations

    Shine bright or live long: substituent effects in [Cu(N^N)(P^P)]+-based light-emitting electrochemical cells where N^N is a 6-substituted 2,2'-bipyridine

    Get PDF
    We report [Cu(P^P)(N^N)][PF6] complexes with P^P = bis(2-(diphenylphosphino)phenyl)ether (POP) or 4,5-bis(diphenylphosphino)-9,9-dimethylxanthene (xantphos) and N^N = 6-methyl-2,2′-bipyridine (Mebpy), 6-ethyl-2,2′-bipyridine (Etbpy), 6,6′-dimethyl-2,2′-bipyridine (Me2bpy) or 6-phenyl-2,2′-bipyridine (Phbpy). The crystal structures of [Cu(POP)(Phbpy)][PF6]·Et2O, [Cu(POP)(Etbpy)][PF6]·Et2O, [Cu(xantphos)(Me2bpy)][PF6], [Cu(xantphos)(Mebpy)][PF6]·CH2Cl2·0.4Et2O, [Cu(xantphos)(Etbpy)][PF6]·CH2Cl2·1.5H2O and [Cu(xantphos)(Phbpy)][PF6] are described; each copper(I) centre is distorted tetrahedral. In the crystallographically determined structures, the N^N domain in [Cu(xantphos)(Phbpy)]+ and [Cu(POP)(Phbpy)]+ is rotated ∼180° with respect to its orientation in [Cu(xantphos)(Mebpy)]+, [Cu(POP)(Etbpy)]+ and [Cu(xantphos)(Etbpy)]+; in each complex containing xantphos, the xanthene ‘bowl’ retains the same conformation in the solid-state structures. The two conformers resulting from the 180° rotation of the N^N ligand were optimized at the B3LYP-D3/(6-31G**+LANL2DZ) level and are close in energy for each complex. Variable temperature NMR spectroscopy evidences the presence of two conformers of [Cu(xantphos)(Phbpy)]+ in solution which are related by inversion of the xanthene unit. The complexes exhibit MLCT absorption bands in the range 378 to 388 nm, and excitation into each MLCT band leads to yellow emissions. Photoluminescence quantum yields (PLQYs) increase from solution to thin-film and powder; the highest PLQYs are observed for powdered [Cu(xantphos)(Mebpy)][PF6] (34%), [Cu(xantphos)(Etbpy)][PF6] (37%) and [Cu(xantphos)(Me2bpy)][PF6] (37%) with lifetimes of 9.6–11 μs. Density functional theory calculations predict that the emitting triplet (T1) involves an electron transfer from the Cu–P^P environment to the N^N ligand and therefore shows a 3MLCT character. T1 is calculated to be ∼0.20 eV lower in energy than the first singlet excited state (S1). The [Cu(P^P)(N^N)][PF6] ionic transition-metal (iTMC) complexes were tested in light-emitting electrochemical cells (LECs). Turn-on times are fast, and the LEC with [Cu(xantphos)(Me2bpy)][PF6] achieves a maximum efficacy of 3.0 cd A−1 (luminance = 145 cd m−2) with a lifetime of 1 h; on going to the [Cu(xantphos)(Mebpy)][PF6]-based LEC, the lifetime exceeds 15 h but at the expense of the efficacy (1.9 cd A−1). The lifetimes of LECs containing [Cu(xantphos)(Etbpy)][PF6] and [Cu(POP)(Etbpy)][PF6] exceed 40 and 80 h respectively
    corecore